삼성서울병원

Ko En

Radiation Oncology Pyo, Hong Ryul M.D

Expertise
Lung cancer, prostate cancer, bladder cancer, thoracic malignancies, genito-urinary malignancies, proton therapy
Treament Schedule 02 月
DATE
THU
01
FRI
02
SAT
03
SUN
04
MON
05
TUE
06
WEB
07
THU
08
FRI
09
SAT
10
SUN
11
MON
12
TUE
13
WEB
14
THU
15
FRI
16
SAT
17
SUN
18
MON
19
TUE
20
WEB
21
THU
22
FRI
23
SAT
24
SUN
25
MON
26
TUE
27
WEB
28
THU
29
AM
PM
Treament Schedule 03 月
DATE
FRI
01
SAT
02
SUN
03
MON
04
TUE
05
WEB
06
THU
07
FRI
08
SAT
09
SUN
10
MON
11
TUE
12
WEB
13
THU
14
FRI
15
SAT
16
SUN
17
MON
18
TUE
19
WEB
20
THU
21
FRI
22
SAT
23
SUN
24
MON
25
TUE
26
WEB
27
THU
28
FRI
29
SAT
30
SUN
31
AM
PM

Medical Education

2002~2005 Ph.D. in Medicine Department of Medical Science, the graduate school, Chungnam University, Korea
1992~1994 Master of Medicine Department of Medical Science, the graduate school, Yonsei University, Korea
1984~1990 Medical Doctor Yonsei University College of Medicine, Korea

Post-Graduate Training

Fellowship   1998~1998 Department of Radiation Oncology, Yonsei University College of Medicine, Korea
Residency   1991~1995 Department of Radiation Oncology, Yonsei University College of Medicine, Korea
Internship   1990~1991 Severance Hospital, Yonsei University College of Medicine, Korea

Professional Appointments

2019~2021 Chair, Department of Radiation Oncology, Samsung Medical Center, Korea
2017~2019 Director, Proton Therapy Center, Samsung Medical Center, Korea
2012~2014 Visiting professor, Department of Radiation Oncology, University of North Carolina School of Medicine, NC, USA
2010~Present Professor, Department of Radiation Oncology, Samsung Medical Center, Korea
2009~2010 Chief Scientist and Radiation Oncologist, Proton Therapy Center, Center for Lung Cancer, National Cancer Center, Korea
2003~2009 Senior Scientist and Radiation Oncologist, Proton Therapy Center, Center for Lung Cancer, National Cancer Center, Korea
2001~2003 Assistant Professor, Department of Radiation Oncology, Yonsei University College of Medicine, Korea
1998~2001 Research fellow, Department of Radiation Oncology, Vanderbilt University Medical Center, TN, USA

Professional Memberships

2005 : American Association for Cancer Research
1995 : Korean Society for Radiation Oncology
1991: Korean Association for Radiation Protection
1991 : Korean Society for Head and Neck Oncology
1991 : Korean Cancer Association
1990 : Korean Medical Association

Selected Publications

  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • RADIOTHER ONCOL 2021 10.1016/j.radonc.2020.12.019 Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy Kim1, N; Noh, JM; Lee, W; Park, B; Park, H; Park, JY; Pyo, H
    View PubMed
  • J THORAC DIS 2020 10.21037/jtd-20-667 Treatment modality and outcomes among early-stage non-small cell lung cancer patients with COPD a cohort study Kang1, N; Shin, SH; Noh, JM; Kang, D; Kim, H; Kwon, OJ; Pyo, H; Ahn, YC; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM; Cho, J; Park, HY
    View PubMed
  • LUNG CANCER 2020 10.1016/j.lungcan.2020.05.035 Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer Jung1, HA; Noh, JM; Sun, JM; Lee, SH; Ahn, JS; Ahn, MJ; Pyo, H; Ahn, YC; Park, K
    View PubMed
  • Journal of thoracic disease 2020 10.21037/jtd.2020.03.23 Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery Shin1, S; Kim, HK; Cho, JH; Choi, YS; Kim, K; Kim, J; Zo, JI; Sun, JM; Ahn, MJ; Park, K; Pyo, H; Ahn, YC; Shim, YM
    View PubMed